Specify a stock or a cryptocurrency in the search bar to get a summary
Genetic Signatures Ltd
GSSGenetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. The company offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, SARS-CoV-2 respiratory plus, coronavirus, atypical respiratory, pertussis and PCP, parainfluenza 4, STI genital pathogen, extended spectrum beta-lactamase and carbapenemase producing organisms, viral meningitis, flavivirus dengue alphavirus, flavivirus reflex, dengue typing, and alphavirus reflex Detection kits under the EasyScreen name. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia. Address: Heart Research Institute, Newtown, NSW, Australia, 2042
Analytics
WallStreet Target Price
1.71 AUDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures GSS
Dividend Analytics GSS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GSS
Stock Valuation GSS
Financials GSS
Results | 2019 | Dynamics |